Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications

Q Zhu, J Xie, W Mei, C Zeng - Cancer Treatment Reviews, 2024 - Elsevier
The intricate epigenetic landscape of hepatocellular carcinoma (HCC) is profoundly
influenced by alterations in DNA methylation patterns. Understanding these alterations is …

Immunotherapy for hepatocellular carcinoma: the next evolution in expanding access to liver transplantation

M Li, S Bhoori, N Mehta, V Mazzaferro - Journal of Hepatology, 2024 - Elsevier
Immunotherapy has revolutionized treatment of advanced hepatocellular carcinoma (HCC).
In addition, several phase III trials of immunotherapy in early-to intermediate-stage HCC in …

[PDF][PDF] Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine

JC Ahn, JD Yang - Clinical and Molecular Hepatology, 2024 - e-cmh.org
The surveillance diagnostic approach for hepatocellular carcinoma (HCC) is fraught with
challenges. Traditional surveillance methods, such as ultrasound imaging and serum …

Lipid Nanovesicle Platforms for Hepatocellular Carcinoma Precision Medicine Therapeutics: Progress and Perspectives

BM Lehrich, ER Delgado - Organogenesis, 2024 - Taylor & Francis
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality
globally. HCC is highly heterogenous with diverse etiologies leading to different driver …

Peripheral CD4+ T cells correlate with response and survival in patients with advanced non-small cell lung cancer receiving chemo-immunotherapy

X Yang, Q Li, T Zeng - Frontiers in Immunology, 2024 - frontiersin.org
Background The aim of the present study was to explore the potential of peripheral immune
cells in predicting the response and prognosis of patients with advanced non-small cell lung …